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Transcriptomic analysis of crustacean
neuropeptide signaling during the moult
cycle in the green shore crab, Carcinus
maenas
Andrew Oliphant1, Jodi L. Alexander2, Martin T. Swain1, Simon G. Webster2 and David C. Wilcockson1*
Abstract
Background: Ecdysis is an innate behaviour programme by which all arthropods moult their exoskeletons. The
complex suite of interacting neuropeptides that orchestrate ecdysis is well studied in insects, but details of the
crustacean ecdysis cassette are fragmented and our understanding of this process is comparatively crude,
preventing a meaningful evolutionary comparison. To begin to address this issue we identified transcripts coding
for neuropeptides and their putative receptors in the central nervous system (CNS) and Y-organs (YO) within the
crab, Carcinus maenas, and mapped their expression profiles across accurately defined stages of the moult cycle
using RNA-sequencing. We also studied gene expression within the epidermally-derived YO, the only defined role
for which is the synthesis of ecdysteroid moulting hormones, to elucidate peptides and G protein-coupled
receptors (GPCRs) that might have a function in ecdysis.
Results: Transcriptome mining of the CNS transcriptome yielded neuropeptide transcripts representing 47
neuropeptide families and 66 putative GPCRs. Neuropeptide transcripts that were differentially expressed across the
moult cycle included carcikinin, crustacean hyperglycemic hormone-2, and crustacean cardioactive peptide, whilst a
single putative neuropeptide receptor, proctolin R1, was differentially expressed. Carcikinin mRNA in particular
exhibited dramatic increases in expression pre-moult, suggesting a role in ecdysis regulation. Crustacean
hyperglycemic hormone-2 mRNA expression was elevated post- and pre-moult whilst that for crustacean
cardioactive peptide, which regulates insect ecdysis and plays a role in stereotyped motor activity during
crustacean ecdysis, was elevated in pre-moult.
In the YO, several putative neuropeptide receptor transcripts were differentially expressed across the moult cycle, as
was the mRNA for the neuropeptide, neuroparsin-1. Whilst differential gene expression of putative neuropeptide
receptors was expected, the discovery and differential expression of neuropeptide transcripts was surprising.
Analysis of GPCR transcript expression between YO and epidermis revealed 11 to be upregulated in the YO and
thus are now candidates for peptide control of ecdysis.
Conclusions: The data presented represent a comprehensive survey of the deduced C. maenas neuropeptidome
and putative GPCRs. Importantly, we have described the differential expression profiles of these transcripts across
accurately staged moult cycles in tissues key to the ecdysis programme. This study provides important avenues for
the future exploration of functionality of receptor-ligand pairs in crustaceans.
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Background
Arthropods are characterised by their rigid exoskeleton
that, although fundamental to their evolutionary success,
must be shed periodically so that they can develop and
grow. The moulting process, termed ecdysis, is achieved
via an innate sequence of behaviours and stereotyped
motor activity, precisely co-ordinated by the interaction
of steroid moulting hormones (ecdysteroids) and a com-
plex suite of interacting neuropeptides. The insect ecdy-
sis programme is arguably the best understood
endocrine cascade among all invertebrates and a consen-
sus model is now emerging (reviews: [1, 2]). Briefly, new
cuticle development is driven by ecdysteroids, which are
synthesised and released from the prothoracic glands
following stimulation by the brain-derived prothoracico-
tropic hormone (PTTH). Subsequently, ecdysteroids ini-
tiate ecdysis triggering hormone (ETH) production in
so-called ‘Inka’ cells (tracheal endocrine cells) and induce
central nervous system (CNS) sensitivity to ETH by pro-
moting ETH receptor (ETHR) expression. Two alterna-
tively spliced ETHRs (ETHR-A & ETHR-B) are
expressed in discrete populations of neurons that are
thought to be differently involved in pre-ecdysis and ec-
dysis [3–5]. ‘Inka’ cells, however only gain secretory
competence when ecdysteroid titre declines below a
threshold level after which they release ETH, which in
turn induces eclosion hormone (EH) release from the
CNS. Together, ETH and EH enter a positive feedback
loop culminating in a massive release of both neuro-
peptides into circulation [6, 7]. In the tobacco horn-
worm, Manduca sexta, the neuropeptide corazonin
(CRZ), a paralog of gonadotropin-releasing hormone,
initiates the release of ETH from ‘Inka’ cells [8]. How-
ever, this is not the case in Drosophila and in some
insects corazonin is entirely absent [9]. Elevated
hemolymph titres of ETH and EH provides a clear
ecdysis signal and commits the animal to the process
by evoking release of the cyclic nonapeptide, crustacean
cardioactive peptide (CCAP), which starts the ecdysis
motor programme and terminates pre-ecdysial behaviours
[10, 11]. Post-ecdysis cuticle maturation, including wing
inflation and cuticle tanning, is regulated by the peptide
bursicon, co-released with CCAP from a sub-set of CCAP
neurons in the abdominal ganglia [12–14]. Our knowledge
on the species-specific actions of ETH, EH, CCAP, and
bursicon is under constant review, but the emerging pic-
ture is that whilst the functions of these neuropeptides are
mostly conserved throughout insects, they may have
subtly different roles in different taxonomic groups and at
different developmental stages.
Whilst our understanding of the control of insect
ecdysis has advanced in recent years, it is relatively
poorly described in crustaceans. Nevertheless, the regu-
lation of insect and crustacean ecdysis has a common
origin in the neuroendocrine system of the crustacean-
like ancestor from which these clades evolved [15, 16]
and so crustacean endocrinology has benefitted from
comparative work done on insects. In crustaceans,
ecdysteroid synthesis occurs in Y-organs (YO) that are
homologous with the prothoracic glands of insects, and
via a common biosynthesis pathway [17]. Perhaps the
defining difference between insect and crustacean
cuticular development and ecdysis is that whilst ecdys-
teroids ultimately co-ordinate the moult cycle in both
insects and crustaceans, ecdysteroid biosynthesis in the
YO is under negative regulation by the eyestalk-derived
neuropeptides, crustacean hyperglycemic hormone (CHH)
and moult-inhibiting hormone (MIH) [18]. In crustaceans,
CHH and MIH, which are part of the structurally related
(but functionally diverse) CHH-superfamily [19] are syn-
thesised in large perikarya concentrated in the so-called
X-organ of the eyestalk medulla terminalis and released
(in the case of MIH) in a pulsatile fashion by exocytosis
from a coalescence of axons emanating from these cells
[20], the sinus gland, into the hemolymph. After circulat-
ing in the hemolymph, CHH and MIH bind to specific
receptors (putatively, GPCRs) on the YO to effect ecdys-
teroid inhibition [18] during intermoult stages (stages
C-D1). Hence the discovery in 1953 in fiddler crabs (Uca)
that removal of eyestalks releases this inhibition and can
lead to precocious moulting [21]. The temporal release of
CHH and MIH implicated in ecdysteroid inhibition in
crustaceans is complicated by species specificity and we
currently lack a consensus model of the events leading to
moulting. This issue is discussed in detail by Webster
(2014) [18]. Whatever the precise order of events, YO
inhibition must be released in premolt and is followed by
elevated ecdysteroid synthesis in stages D1-D3. Down-
stream of ecdysteroid synthesis our understanding of
crustacean moult control is fragmentary at best and there
is currently no consensus on the endocrine cascade that
culminates in ecdysial behaviour and cuticle tanning. Thus
far we know that, during ecdysis (stage E) CHH is dramat-
ically released from paraneurons in the fore and hind-gut
whilst CCAP and bursicon are co-released from the peri-
cardial organs, and concomitant with the onset of ecdysis
motor programme that precedes post-ecdysial tanning
and cuticle hardening [18, 22] (during stages A-C). Thus,
the activities of CCAP and bursicon may be generally con-
served between crustaceans and insects [18, 22]. Broadly
then, our knowledge of the neuropeptides involved in the
regulation of crustacean ecdysis, such as CCAP and bursi-
con, indicate that some elements are conserved across
arthropods whilst others are strikingly different (e.g.
ecdysteroid regulation). Our inadequate understanding of
key elements (and their roles) of the neuroendocrine
control of crustacean ecydsis precludes a meaningful evo-
lutionary comparison with the process in insects.
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Until recently, the discovery and characterization of
neuropeptides relied on the laborious purification of
native peptides from animal tissues coupled with manual
peptide sequencing or mass spectrometry (e.g. [23, 24]).
Today, next generation sequencing (NGS) strategies have
become routine and relatively inexpensive and coupled
with emerging informatics pipelines have accelerated pep-
tide mRNA transcript discovery and characterization [25].
This new era of whole transcriptome sequencing has
generated a surge in neuropeptide discovery in non-model
species, including crustaceans, overcoming their previous
genetic intractability (e.g. [26–29]). A consequence of this
post-genomic era is a widening gap between the descrip-
tion and characterization of conceptual peptide genes and
their cognate peptide products and in vivo functions.
Through NGS and transcriptome mining within crusta-
ceans, orthologs of insect neuropeptides have been
documented [27], but functional roles for these peptides
remain lacking. Similarly, whilst the receptors for numer-
ous neuropeptides have been functionally demonstrated
for insects, only a few G protein-coupled receptors
(GPCRs) have been de-orphanised among crustaceans [30,
31] and so identification of their GPCRs lags considerably
behind. Indeed, only recently have efforts been focussed
on revealing the structural identity of putative GPCRs in a
crustacean, the spiny lobster Sagmariasus verreauxi [32].
Here, we sought to shed light on the involvement of
neuropeptides in crustacean ecdysis by using
RNA-sequencing to identify neuropeptides and putative
neuropeptide GPCRs in the CNS and YO of the green
shore crab, Carcinus maenas and against the insect system
as a framework for our exploration. Thus, we describe a
comprehensive suite of neuropeptide and receptor tran-
scripts in C. maenas and define their expression profiles
across the moult cycle at precisely defined moult stages.
This study is the first exploration of a multi-tissue crust-
acean neurotranscriptome across the moult cycle with
high temporal precision and therefore provides the oppor-
tunity to elucidate putative neuropeptide signaling during
the crustacean ecdysial programme and draw comparisons
with the current insect model.
Methods
Carcinus maenas were collected from the Menai Straits,
UK using baited traps and held in a flow through
aquaria at Bangor University until use. Aquarium
conditions were: water temperature = 16 °C, salinity
=35 (full seawater), light:dark cycle = 12:12. Aquarium
conditions did not replicate ambient tidal cycles.
Crabs were fed ad libitum twice per week and were
kept for no more than 4 weeks. Crabs were collected
and dissected throughout the spring and summer
months when moulting is prevalent.
Total RNA extraction, cDNA library preparation, and
sequencing
Total RNA was harvested from crabs dissected across
the moult cycle at stages A-B, C3–4, D1, D3, D4 (stages
according to Phlippen et al. [33]) for n = 5 animals (bio-
logical replicates) per moult-stage. Three sets of tissues
were collected for transcriptome sequencing and were
subsequently analysed independently due to the consider-
able volume of data which sequencing yielded (see Add-
itional file 1: Table S5, S6, and S7, for further details on
sequenced data sets). The first consisted of central ner-
vous system tissues (CNS: eyestalk ganglia [ESG], cere-
bral ganglion [CG], and ventral ganglion [VG]
comprising the fused sub-oesophageal [SOG], thoracic
[TG], abdominal ganglia [AG]); the second, pairs of
Y-organs (YO); and the third consisted of inter-moult
(C3–4) pairs of YOs and epidermis from the bran-
chiostegite region of the carapace (overlying the pleural
suture posterior of the YO). These tissues were dissected
from ice-anaesthetised C. maenas under ice-cold physio-
logical saline [34], using dedicated instruments for each
tissue. Tissues were snap frozen in liquid nitrogen before
storage at − 80 °C until use. Tissues were homogenised in
TRIzol reagent in a Qiagen TissueLyser LT (Qiagen, UK)
for 1 min (CNS and YO tissues) or 3 min (epidermis) at
50 Hz with a 5 mm stainless steel bead and RNA extracted
according to the manufacturer’s protocol except additional
ethanol washes were performed prior to resuspension of
the RNA pellet in DEPC-treated water. RNA integrity was
assessed by gel electrophoresis (Additional file 1: Figure
S1) whilst yield and purity were measured spectrophoto-
metrically with a NanoDrop ND2000™ (Thermo Scientific,
UK). cDNA library preparation was done using Illumina
TruSeq RNA sample preparation reagents according to
the manufacturer’s protocol. For CNS tissue cDNA library
preparation, equal quantities (1 μg) of total RNA taken
from separate neural tissues (ESG, CG, VG) were pooled.
Library quality was assessed by gel electrophoresis and
quantified using a Qubit 2.0 Fluorometer (Invitrogen™,
Thermo Fisher, UK) prior to sequencing. Paired-end
126-bp reads were sequenced across multiple lanes on an
Illumina HiSeq 2500 platform. Library preparation, quality
checks and sequencing were done in-house at the Transla-
tional Genomics Facility, IBERS, Aberystwyth University.
Transcriptome assembly, characterization, and differential
gene expression analysis
Comparisons of various de novo assembly software
packages demonstrate that no single assembler is univer-
sally superior [35, 36]. To thoroughly evaluate the poten-
tial of the sequenced raw reads, multiple assemblers
were used for de novo transcriptome assembly of CNS
reads and the resulting transcriptomes compared: Trin-
ity v2.0.6 [37], Oases v0.2.8 [38] (which used Velvet
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v1.2.10 [39]), IDBA-tran v1.1.1 [40], and BinPacker v1.1
[41]. Prior to assembly, a 13-bp head crop of raw reads
was done [42] followed by trimming and in silico read
normalisation using the Trinity options --trimmomatic
[43] and --normalize_reads. Both options were run with
default settings (trimmomatic: phred33, SLIDINGWIN-
DOW:4:5 LEADING:5 TRAILING:5 MINLEN:25, based
on [44]). Trimmed and normalised reads were assembled
with default settings in each of the four assemblers
(k-mer length: Trinity k = 25; Oases k = 23, 27, 31;
IDBA-tran k = 20, 30, 40, 50, 60; BinPacker k = 25). Com-
parisons of these four transcriptome assemblies revealed
the Trinity assembly to be superior in terms of the
number and completeness of C. maenas neuropeptide
transcripts assembled as well as number and completeness
of UniProt/Swiss-Prot BLAST hits (for details see
Additional file 1: Table S1, Figures S2 and S3).
Consequently, Trinity was used for the assembly of
transcriptomes in the current study. Transcriptomes
for CNS and YO tissues sampled across the moult
cycle, and for inter-moult (C3–4) YO and epidermis
tissues, were assembled separately. For each
transcriptome, Trinity transcripts were clustered into
‘genes’ using Corset v1.06 [45], which clusters tran-
scripts based on sequence similarity and read counts
(generated by Bowtie v1.0.1 [46] with multi-mapping en-
abled). These Corset-clustered Trinity transcriptomes
(herein referred to as the Carma_CNS-transcriptome,
Carma_YO-transcriptome, and Carma_YO_vs_Epi-tran-
scriptome) were annotated using Trinotate v2.0.1 and as-
sociated software (TransDecoder v2.0.1, BLAST v2.2.31+,
HMMER v3.1, SignalP v4.1, TMHMM v2.0, RNAMMER
v1.2, TrinotateR). The process of Corset clustering, which
used Bowtie generated mapping data, outputs a counts file
for use in differential expression analysis [45]. For
Carma_CNS- and Carma_YO-transcriptomes, differential
cluster expression was performed using the edgeR package
[47] (with the glm method to enable multiple compari-
sons) and by comparing inter-moult (C3–4) stage count
data with that from each of the other four moult stages
(A-B, D1, D3, and D4). For the Carma_YO_vs_Epi-tran-
scriptome, differential cluster expression was performed
by comparing count data between YO and epidermis tis-
sues, again using the edgeR package [47]. Bowtie mapping,
Corset clustering and counting, and edgeR differential
expression analysis followed the example Corset pipeline
at: github.com/Oshlack/Corset/wiki. The three transcrip-
tomes assembled as part of this Transcriptome Shotgun
Assembly project have been deposited at DDBJ/EMBL/
GenBank under the accessions: GFXF00000000
(Carma_CNS-transcriptome), GFYV00000000 (Car-
ma_YO-transcriptome), and GFYW00000000 (Car-
ma_YO_vs_Epi-transcriptome). The transcriptomes
have also been made available as publically accessible
BLAST databases at: sequenceserver.ibers.aber.ac.uk.
Raw read sequence files used to generate these
assemblies are archived in the NCBI SRA archive
under BioProject PRJNA400568. Trinotate annotation
reports for Carma_CNS-, Carma_YO-, and Car-
ma_YO_vs_Epi-transcriptome are provided in Add-
itional file 2 as well as transcripts for neuropeptides
and putative neuropeptide receptors mined from Car-
ma_CNS- and Carma_YO-transcriptomes.
Neuropeptide and receptor discovery
The Carma_CNS- and Carma_YO-transcriptomes were
mined for contigs coding for putative neuropeptides
using local tBLASTn searches with sequences from C.
maenas and related species as search terms (performed
in BioEdit software, [48]). Short protein motifs in open
reading frames (ORFs) identified by TransDecoder were
also searched in BioEdit. Peptide sequences used as
search terms were taken from the NCBI [49] database
and from recent literature [26, 27, 50, 51]. BLAST
e-value and sequence identity thresholds considered
significant between query peptide sequences and BLAST
hits were assessed case-by-case. Contigs mined as puta-
tive neuropeptides were translated using the online tool
ExPASy Translate (web.expasy.org/translate, [52]) and
signal peptides identified with SignalP v.4.1 Server (set
to ‘Sensitive’ to reproduce SignalP v.3.0’s sensitivity,
[53]). Convertase cleavage sites were predicted following
[26, 51, 54] and basic amino acid residues removed by
carboxypeptidase were identified. Neuropeptide prepro-
hormone processing and deduced mature peptides and
precursor-related peptides (PRPs) have been made avail-
able in Additional file 3. Cysteine-cysteine disulfide
bridges were predicted with the online tool: disulfind.d-
si.unifi.it. Contigs coding for putative neuropeptide
GPCRs were also mined using local tBLASTn searches
with sequences taken from the NCBI database for Dros-
ophila and Tribolium casteneum. Whilst there are
studies which have sought to identify crustacean neuro-
peptide GPCRs based on sequence similarity to known
neuropeptide GPCRs (e.g. [29, 32, 51]), until recently no
crustacean neuropeptide GPCR had been de-orphanised
[30, 31]. For this reason predicted receptors were identi-
fied as a result of searching using search terms for Tri-
bolium casteneum and Drosophila receptors, for which
functional de-orphanisation has been achieved. GPCR
transmembrane helix domains were predicted using
TMHMM server v.2.0 (cbs.dtu.dk/services/TMHMM,
[55, 56]). Amino acid alignments were done in BioEdit
via the ClustalW method [57]. Phylogenetic trees were
constructed using the Neighbor-Joining method (1000
bootstrap replicates) [58] in MEGA6 [59]. Drosophila mel-
anogaster metabotropic Glutamate Receptor (CG11144
mGLuR) was used as an outgroup to root phylogenetic
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trees for class A (rhodopsin-like), class B (secretin-like),
and leucine-rich repeat-containing GPCRs (LGR) trees.
Drosophila melanogaster trissin (NP_650471.1) was used
as an outgroup to root the tree for the ETH, carcikinin,
and carcikinin-like peptides phylogenetic tree.
Quantitative RT-PCR
Quantitative RT-PCR assays were developed and per-
formed according to previously published methods [60]
using Taqman™ MGB probes and in close adherence to
MIQE guidelines [61]. In brief, standard curves were
made by generating complementary RNA in vitro with
T7 RNA polymerase (MegaShort Script™, Ambion®, UK)
using PCR derived DNA templates amplified with T7
phage promotor sequence flanked gene specific primers.
All oligonucleotide sequences for cRNA preparations
and Taqman assays are detailed in Additional file 1:
Table S2. Complementary RNA was purified on 10%
6 M urea PAGE gels and eluted in Elution Buffer
(Ambion®, Thermo fisher, UK) overnight at RT before
ethanol precipitation. Resulting cRNA was quantified
spectrophotometrically, converted to copy number using
Avogadro’s constant and diluted in DEPC-treated water
and stored at − 80 °C until use. Standard curves were
run in the range 109 to 103 copies per reaction. Sample
and standard RNA was reverse transcribed using Tetro™
reverse transcriptase (Bioline, UK) according to the
manufacturer’s instructions and diluted in water 1:10 for
PCR. Assays were run in triplicate on an Applied Biosys-
tems® Quant Studio 12 Flex platform (Thermo-Fisher
Scientific, UK) in 10 μL volumes using Sensimix Fast II
probe™ qPCR mix with ROX internal reference dye (Bio-
line, UK). Data were expressed as copies of target mRNA
normalized to the geometric mean of the reference
genes elongation factor 1-alpha (EF1a) and ubiquitin--
conjugating enzyme E2 L3 (UBE2L3) shown to be consti-
tutively expressed across all moult stages with RNAseq
analysis (Additional file 1: Figure S4).
End-point PCR
End-point PCRs were performed for cDNAs encoding
eclosion hormones 1 and 2, crustacean hyperglycemic
hormone 2, and the reference gene elongation factor
1-alpha, to establish the tissue distribution of these tran-
scripts. Tissues were dissected, and total RNA extracted,
and RNA reverse transcribed for 5 inter-moult (C4)
crabs as outlined above. cDNA of n = 5 individuals was
pooled for end-point PCR, which was performed using
Bioline myTAQ red mix on a Bio-Rad T100 thermal cy-
cler. PCR conditions were: denature at 95 °C for 3 mins,
then 35 cycles of 30 s at 95 °C, 45 s at 60 °C, and 45 s at
72 °C, followed by extension at 72 °C for 5 mins. PCR
products were resolved on 1% agarose gels.
Results and discussion
Transcriptome assembly and annotation summary data
are detailed in Additional file 1.
Neuropeptide discovery and expression
Carma_CNS-transcriptome
Of the 52 neuropeptide families searched for, representa-
tives of 47 were discovered: 104 transcripts (from 87
clusters) were identified, predicted to encode for 59
full-length peptides or proteins (comprising a ‘start’
methionine, a signal peptide, and a stop codon), 24
C-terminal partial proteins (6 of which contained partial
signal peptides), 13 N-terminal partial proteins and 8 in-
ternal (lacking both termini) fragments (see Additional files 2
and 3). Analysis of post-translational processing of these
conceptual proteins predicts 160 unique mature peptides
and 185 precursor-related peptides (PRPs) (see Additional
file 3). This is likely an under-estimate of the total number
of mature peptides encoded in this transcriptome as
prepro-hormones of some neuropeptides contain multiple
copies of identical mature peptides (e.g. a HIGSLYamide
C-terminal partial protein contained 6 identical mature
peptides; see Additional file 3). For Daphnia pulex, 43
genes encoding 73 neuropeptides were predicted in silico;
mass spectrometry confirmed 40 of these by mass matching
and 30 by fragmentation sequencing [62]. Within the Dros-
ophila genome, some 42 genes encode neuropeptide pre-
cursors predicted to produce approximately 75 mature
peptides although the translation of many of these tran-
scripts has not been confirmed in vivo [63]. Comparatively,
the number of neuropeptide precursors identified, and ma-
ture peptides predicted here for C. maenas appears large.
However, recent efforts mining decapod transcriptomes
have yielded similarly large numbers of transcripts coding
for neuropeptide precursors and mature peptides. For
example, Christie (2016) identified transcripts from 29
neuropeptide families predicted to produce approximately
112 mature peptides (in addition to 151 PRPs) for C. mae-
nas [26]. Furthermore, Veenstra (2015) identified 58 tran-
scripts encoding neuropeptides from some 41 families for
the crayfish Procambarus clarkii [51] and in a substantial
transcriptome mining effort, Veenstra (2016) identified 66
‘genes’ from 47 neuropeptide families for C. maenas as well
as comparable values for Scylla paramamosain (59 ‘genes’,
45 neuropeptide families), Eriocheir sinensis (68, 49), Litope-
naeus vannamei (70, 49), Macrobrachium rosenbergii (67,
48), Homarus americanus (59, 45), and Procambarus clarkii
(63, 49) [27]. Mining efforts for chelicerate transcriptomes
and genomes have yielded yet greater numbers of neuro-
peptide precursors, a result of paralog genes from genome
duplications: e.g. 87 and 79 neuropeptide precursors for the
spider Stegodyphus mimosarum and the scorpion Meso-
buthus martensii, respectively [64].
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For C. maenas, the production of 122 mature peptides
within the CNS and neuro-endocrine organs has been
confirmed by mass spectrometry [65]. Numerous mature
peptides predicted in silico here and elsewhere for C.
maenas, or confirmed biochemically, are identical or
very similar isoforms [26, 65]. Whether such isoforms
are physiologically redundant or serve distinct functions
is undetermined [63]. For example, the 25 mature
allatostatin-As detected in the C. maenas CNS by mass
spectrometry comprise the characteristic YXFGLamide
C-termini but, differ in N-termini sequence [65]. Here, a
single putative allatostatin-A GPCR was discovered (see
below, Table 2), suggesting that the 25 or so isoforms
may indeed be physiologically redundant, although this
has yet to be functionally determined. In this context, it
is interesting to note that there is evidence for neuro-
peptide redundancy in Drosophila [66]. Of course, we
should not ignore an alternative scenario that further
allatostatin receptors are present but were not predicted
in the current analysis. As for all predicted GPCR and
their putative ligands, functional de-orphanisation is the
only way to clarify the actual situation.
Representatives from allatotropin, androgenic gland
specific insulin-like peptide (IAG), DENamide, DXXRLa-
mide, and FXGGXamide families were absent from the
Carma_CNS-transcriptome. The discovery of DENa-
mides is so far limited to the cladoceran water flea, D.
pulex [62] whilst DXXRLamides and FXGGXamides
have been identified only in copepods [67]. Like DENa-
mide, allatotropin is present in D. pulex and the cope-
pods Tigriopus californicus and Lepeophtheirus salmonis
and putative allatotropins are present in the transcrip-
tomes of the amphipods, Talitrus saltator (NCBI:
PRJNA297565) and Hyalella azteca (NCBI:
XM_018171664.1; see Additional file 1: Figure S5).
Given that allatotropin is present in molluscs, annelids,
and chelicerates, it is presumably an ancient neuropep-
tide which may have been lost in decapod crustaceans
[27]. Androgenic gland specific insulin-like hormone has
been identified in a number of decapods, but the same
study failed to find it in C. maenas [27]. In studies re-
ported to date [68] IAG was found only in the andro-
genic gland and it is not therefore, surprising that we
did not sequence its transcript in C. maenas and its ex-
istence in this species should not be ruled out. We were
able to identify a transcript for CHH-MIH-like neuro-
peptide (the function of which is unknown) previously
described in other decapods, but until now absent from C.
maenas [27]. The diversity of neuropeptides discovered
here from the Carma_CNS-transcriptome is consistent
with other studies on C. maenas and comparable with
other decapods [26, 27, 65].
Of the 87 neuropeptide contig clusters identified, 9
were excluded from differential gene expression analysis
because of very low read numbers (< 1 read per million
in > 3 samples) [45]. Our analysis revealed that only 5
neuropeptides were differentially expressed across the
moult cycle: carcikinin/ecdysis triggering hormone
(ETH), crustacean hyperglycemic hormone-2 (CHH-2),
crustacean female sex hormone (CFSH), crustacean car-
dioactive peptide (CCAP), and neuroparsin-3 (P < 0.05,
FDR < 0.05; Table 1).
Carcikinin/ecdysis triggering hormone (ETH)
The transcripts for a neuropeptide, here assigned the
name ‘carcikinin’, exhibited the highest magnitude of
differential expression of all clusters across the moult
cycle in the Carma_CNS-transcriptome (Fig. 1). Three
transcripts encoding carcikinin prepro-hormones were
identified: two were full prepro-hormone transcripts and
one was an N-terminal partial sequence with an
N-terminal extension upstream of the signal peptide
(Additional file 1: Figure S6; see also Additional files 2
and 3). Such N-terminal extensions were also observed
for other prepro-hormones identified here (and that
have been reported in other in silico mining studies)
though whether these are assembly artefacts or have
some biological function is yet undetermined [26]. Of
the two deduced full-length precursor peptides, one
was 136-aa and the other was truncated at 61-aa
(Additional file 1: Figure S6). Both precursors have
identical 19-aa signal peptides and 16-aa mature pep-
tides (DAGHFFAETPKHLPRIamide) but differ in their
precursor-related peptides (PRPs) (Additional file 1:
Figure S6; see also Additional file 3).
In silico expression data revealed that carcikinin tran-
script abundance was low in post-, inter-, and early
pre-moult (moult stages A-B, C3–4, and D1, respect-
ively), but increased dramatically during pre-moult
stages, D3 and D4 (Fig. 1). Given the importance of
ETH to insect ecdysis, coupled with our intriguing in
silico data which showed not only that carcikinin was
differentially expressed across the moult cycle but that
transcript abundance increased strikingly in late
pre-moult, we adopted a more targeted quantitative PCR
approach to validate in silico data and measure expres-
sion of selected genes of interest within defined regions
of the CNS. We observed a considerable increase in car-
cikinin expression during D3 and D4, consistent with in
silico data: two-way ANOVA indicated that there was a
significant interaction between tissue type and moult
stage on carcikinin expression (F(8, 63) = 2.218, P =
0.0376) with dramatically increased expression in the
VG at stages D3 and D4 (Tukey’s post-hoc analysis, P <
0.05; Fig. 1B). This expression pattern across the moult
cycle strongly suggests a role for VG derived carcikinin
in the regulation of ecdysis within C. maenas and per-
haps decapod crustaceans generally (Fig. 1).
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Carcikinin has previously been identified as a crust-
acean orthologue of insect ecdysis triggering hormone
(ETH), e.g. [27], and a carcikinin-like neuropeptide iden-
tified in the genome of the myriapod, Strigamia mari-
tima, was assigned the name ETH in that study [50]. In
a phylogenetic analysis of insect and D. pulex ETHs,
crustacean carcikinins, and carcikinin-like peptides
mined from the transcriptomes of other arthropods,
crustacean carcikinins were clustered in a high confi-
dence branch. A myriapod/chelicerate branch and a
separate chelicerate only branch also clustered with high
confidence. Insect ETHs were clustered into two high
confidence branches, one lepidopteran and the second
consisting of dipterans and hymenopterans, which
excluded T. casteneum (Fig. 2). The branchiopod crust-
acean, D. pulex, was excluded from carcikinin/carcikinin--
like peptides and ETH branches. Whether differences in
the peptide sequences of insect ETHs and carcikinin/car-
cikinin-like peptides reflect phylogenetic differences
between insects and other arthropods, or indicate that
ETH and carcikinins/carcikinin-like peptides are distinct
peptides is unclear. D. pulex neuropeptides have been
found to be more closely related to insect, rather than
decapod, homologs and this has been interpreted to con-
firm that branchiopods are an ancestral group to insects
[62]. As such, carcikinin/carcikinin-like peptides may
represent a more primitive ETH, common across arthro-
pods. Certainly, amino acid residues within the mature
peptide are conserved across arthropods (Fig. 2).
Insect ETH is synthesised and released from peripheral
endocrine ‘Inka’ cells located in the trachea and PETH
immunochemical localization has revealed peripheral
cells in pharate nymphs of the ticks Ixodes ricinus and
Rhipicephalus appendiculatus [69]. Given the peripheral
localization and expression of these peptides in insects it
is possible that a true crustacean ETH homolog has been
missed in the current and previous studies that have
harvested material from neural tissues; though it is
interesting to note that the only ‘ETH’ identified in
the myriapod genome is carcikinin-like (Fig. 2). A
fully annotated decapod genome is clearly requisite
and would be timely.
Table 1 Neuropeptide transcript differential expression statistics
Neuropeptide Cluster LogFC F P FDR
A-B D1 D3 D4
Carcikinin/ETH Cluster-5052.1 1.18 2.31 4.4 5.9 47.91 5.42E-11 2.63E-06
CHH-2 Cluster-569.33175 2.76 0.04 1.6 3.21 7.14 0.001 0.023
Neuroparsin-3 Cluster-141,623.0 −1.27 1.68 −0.32 0.14 7.03 0.001 0.024
CFSH Cluster-126,814.0 3.74 5.66 4.19 0.72 6.4 0.001 0.034
CCAP Cluster-569.9440 −0.62 −0.93 − 0.32 0.22 6.66 0.002 0.041
Bursicon-α Cluster-129,891.0 −0.57 −1.17 − 0.16 0.3 5.36 0.003 0.062
Bursicon-β Cluster-121,462.0 −0.54 −1.1 − 0.07 0.21 5.02 0.005 0.076
Allatostatin-CC Cluster-154,370.0 −0.35 − 0.9 0.02 0.22 5.52 0.008 0.112
Differential gene expression analysis statistics for five C. maenas neuropeptides which were differentially expressed across the moult cycle (P < 0.05 and FDR <
0.05, bold font above line) and three non-differentially expressed neuropeptides (P < 0.05 but FDR > 0.05, below line) within the CNS. LogFC are relative to moult
stage C3–4. The P-value should be read in conjunction with the false discovery rate (FDR)
Fig. 1 Carcikinin/ETH gene expression across the moult cycle within the central nervous system of C. maenas, determined by A RNAseq and
B qPCR. For qPCR data, carcikinin/ETH mRNA copy numbers are normalized to the geometric mean of the reference genes elongation factor
1-alpha and ubiquitin-conjugating enzyme E2 L3 (data are expressed as mean + SEM). In silico data are presented as mean counts per million
(CPM, mean + SEM). ESG = eyestalk ganglia, CG = cerebral ganglia, VG = ventral ganglia
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Eclosion hormones (EHs)
Two eclosion hormone (EH)-like ‘genes’ were identified
in our Carma_CNS-transcriptome (EH-1 and EH-2; see
Additional files 2 and 3), consistent with other in silico
mining studies of this species and other decapods
[26, 27]. The presence of two crustacean EHs is in
contrast to insects that invariably have only one. In
insects, EH is expressed in ventro-median (Vm) cells
of the cerebral ganglion, which project axons through
the ventral ganglia and their connectives to procto-
deal nerves on the hindgut [7]. As alluded to earlier,
in the insect ecdysis cascade EH forms a positive
A
B
Fig. 2 A Amino acid alignment for insect pre-ecdysis triggering hormone (PETH), ecdysis triggering hormones (ETH) 1 and 2, and carcikinin, and
carcikinin-like peptides from crustaceans, myriapods and chelicerates. Identical residues are highlighted black and conserved substitutions are
highlighted grey. B Phylogenetic tree of insect ETHs, carcikinin, and carcikinin-like peptides constructed using the Neighbor-joining method.
Nodes supported by bootstrap values of < 50% have been collapsed. Protein sequences for Scylla paramamosain, Eriocheir sinensis, Homarus
americanus, Procambarus clarkii, Litopenaeus vannamei, and Macrobranchium rosenbergii taken from [27]. Accession codes for sequences taken
from the NCBI database: Cancer borealis, GEFB01012879.1; Meganyctiphanes norvegica, GETT01085899.1; Scolopendra subspinipes dehaani,
GBIM01000685.1; Pardosa pseudoannulata, GCKE01050112.1; Parasteatoda tepidariorum, XM_016075645.1; Nothrus palustris, GEYJ01054236.1;
Tetranychus urticae, XM_015935221.1; Daphnia pulex, EFX73380.1; Choristoneura fumiferana, JX878448.1; Manduca sexta, AF165427.1; Bombyx
mori, NM_001172272.1; Tribolium castaneum, XM_008196841.2; Drosophila melanogaster, NM_079960.4; Sarcophaga crassipalpis, LC018445.1;
Apis mellifera, NM_001142607.1; Nasonia vitripennis, NM_001142635.1; Drosophila melanogaster Trissin, NP_650471.1
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feedback loop with ETH, resulting in the near total
release of EH and ETH and signaling the start of ec-
dysis. ETH in turn initiates pre-ecdysis behaviours
whilst EH evokes CCAP and bursicon release, thus
committing the animal to ecdysis and terminating
pre-ecdysial events [11]. However, recent evidence
from Drosophila suggests that this view is rather
simplistic and that EH may be critical to the initi-
ation of pre-ecdysis behaviours, at least in flies [70].
In the present study, C. maenas EH-2 was represented
by a single contig encoding a full length protein but was
excluded from differential expression analysis because so
few reads were counted for the transcript, indicating ex-
tremely low expression levels in the CNS. Endpoint PCR
of inter-moult animals revealed that EH-2 mRNA is
expressed across multiple tissues at low levels (but see
below); EH-1 is also expressed across multiple tissues,
but at much higher levels (Additional file 1: Figure S7).
EH-1 was not differentially expressed across the moult
cycle (F = 1.71, P = 0.18, FDR = 0.70; Fig. 3), but given
the importance of EH in insect ecdysis, we thought it
worthy of further investigation. In silico gene expression
was validated by qPCR which also revealed the primary
location of EH-1 expression within the CNS to be the
eyestalk ganglia (ESG; Fig. 3B). Two-way ANOVA to test
for the effects of moult stage and tissue type on EH-1
expression showed no interaction effect (F(8,63) = 2.04, P
= 0.059) but main effects analysis indicated that the
mRNA expression in the eyestalk was significantly
greater than that in the cerebral and ventral ganglia
(F(2,71) = 139.26, P < 0.001; Bonferroni post hoc P < 0.05)
(Fig. 3B). The presence of two EHs, coupled with the
expression of EH-1 mRNA predominantly in the eye-
stalks of C. maenas suggests likely differences in the
neural architecture of EH producing cells and perhaps
EH functioning between insects and crustaceans. Given
the fundamental role insect EH plays in insect ecdysis, the
localization and functional characterization of crustacean
EHs (especially EH-1) and their neural architecture are a
priority.
Crustacean cardioactive peptide (CCAP)
Three CCAP transcript variants were discovered and
assigned to a single cluster, the translated sequences of
which were identical in their first 137-aas (and thus pro-
duced identical mature nonapeptides: PFCNAFTGCa-
mide) but differed in their C-termini and therefore the
CCAP PRPs that they encode (Additional file 1: Figure
S8; see also Additional file 3). CCAP PRPs and other
neuropeptide PRPs may serve important physiological
functions, but to date little evidence for their roles
exists. CCAP mRNA was found to be differentially
expressed across the moult cycle (P < 0.05 and FDR <
0.05; Table 1, Fig. 4) and had a strikingly similar expres-
sion profile to those of bursicon-α, bursicon-β, and
allatostain-CC(part a), which were constitutively expressed
across the moult cycle (P-values < 0.05, but FDR > 0.05;
Table 1, Fig. 4). Analysis revealed strong positive correla-
tions between CCAP and bursicon-α, −β, and Ast-
CC(part a) gene expression (Fig. 4E, F, G). The gene ex-
pression profiles observed here for CCAP and bursicon
agree with those observed (via qPCR) in other studies of
C. maenas [71, 72]. Levels of CCAP and buriscon pep-
tides in the pericardial organs of C. maenas are closely
coupled across the moult cycle whilst levels in the
fused ventral ganglion are coupled during inter- and
pre-moult, but become uncoupled during ecdysis and
post-moult [22].
In insects, CCAP release is stimulated by EH and initi-
ates the ecdysis motor programme whilst halting pre-ec-
dysis behaviours. Bursicon is co-released with CCAP to
initiate the ecdysis motor programme and post-ecdysis
cuticle tanning and wing inflation [10, 11]. CCAP and
bursicon have been reported to perform similar func-
tions in C. maenas [18, 22]. Within C. maenas, CCAP
and bursicon are co-localised in paired, segmentally
Fig. 3 Eclosion hormone-1 gene expression dynamics measured across the moult cycle and within the central nervous system of C. maenas,
determined by A RNAseq and B qPCR. For qPCR data, eclosion hormone-1 mRNA copy numbers are normalized to the geometric mean of the
reference genes, elongation factor 1-alpha and ubiquitin-conjugating enzyme E2 L3 (data expressed as mean + SEM). In silico data are presented as
means counts per million (CPM + SEM). ESG = eyestalk ganlia, CG = cerebral ganglia, VG = ventral ganglia
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repeating perikarya of the ventral ganglion [22, 72].
Given that CCAP and bursicon expression also appears
coupled with that of Ast-CC, it would be interesting to
explore whether Ast-CC is co-localised in the CCAP-bur-
sicon neurons of the ventral ganglion. In Drosophila,
CAMB neurons (so called because they produce CCAP,
Allatostatin-CC, Myoinhibitory peptide, and Bursicon)
comprise the ‘master switch’ of ecdysis behaviour follow-
ing exposure to ETH [73]. Co-localisation of Ast-CC as
well as CCAP and bursicon in the paired, segmentally
iterated perikarya of the ventral ganglion would indi-
cate that these neurones might be the crustacean
equivalent of the fruit fly CAMB neurons and thus,
clearly warrant further study.
Crustacean hyperglycemic hormone (CHH) neuropeptide
family
The CHH-superfamily comprises structurally related neu-
ropeptides including type-I peptides: crustacean hypergly-
cemic hormone (CHH) and insect ion transport peptides
(ITP); and type-II peptides: moult inhibiting hormone
(MIH), vitellogenesis-inhibiting hormone (VIH), and man-
dibular organ-inhibiting hormone (MOIH) [19, 73–75].
CHH neuropeptides are involved in numerous physio-
logical events with reported biological activities including
regulation of carbohydrate metabolism, osmo and iono-
regulation, moulting, gonad maturation, and methyl
farnesoate synthesis by the mandibular organ [19]. Here,
two CHHs, an MIH, and (for the first time) a CHH-MIH--
like neuropeptide transcript were identified (see Add-
itional files 2 and 3). For each of the CHHs (CHH-1 and
CHH-2), two transcript variants were assembled, differing
from one-another in their C-terminal regions in the trans-
lated sequence (Additional file 1: Figure S9). In a study
mining decapod transcriptomes, Veenstra (2016) identi-
fied two C. maenas CHHs, naming them CHH-1 and
CHH-2. CHH-1 was already known, having been
discovered by traditional methods [76], the second
(CHH-2) was newly discovered [27]. Here, we have
adhered to the naming of CHHs CHH-1 and CHH-2
Fig. 4 Gene expression profiles across the moult cycle within C. maenas central nervous system for: A crustacean cardioactive peptide (CCAP), B
bursicon-α, C bursicon-β, and D allatostatin-CC, determined by RNAseq. Data are expressed as CPM, mean + SEM. Correlations of gene expression
(determined by RNAseq) between CCAP and E bursicon-α, F bursicon-β, and G allatostatin-CC. Pearson’s correlation statistics are shown inset
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according to that of Veenstra (2016) [27]. CHH-1 has
been the focus of numerous studies investigating the func-
tion of CHH within crustaceans (see below). The concep-
tual CHH-1s identified here correspond to those
sequenced from C. maenas pericardial organs (CHH-1a)
and the X-organ-sinus gland (CHH-1b) [77] (Additional
file 1: Figure S9). The signal peptides and precursor
related peptides (CPRP) produced by the two CHH-1 vari-
ants correspond to published sequences [27, 77]. To our
knowledge, no functional characterisation has been done
on CHH-2. Both CHH-2 s have 27-aa signal peptides and
20-aa CHH-precursor-related proteins which have
C-terminal amidation signals; however, CHH-2a and b
differ in their mature peptides (Additional file 1: Figure
S9; see also Additional file 3). Consistent with CHH super-
family peptides, the 83-aa CHH-2a mature peptide
has 6 cysteine residues but the 73-aa CHH-2b mature
peptide has only 4. The CHH-MIH-like neuropeptide
is 128-aa with a 26-aa signal peptide and a 102-aa
mature peptide containing 6 cysteine residues (see
Additional files 2 and 3).
Three MIH transcript variants were identified from two
isoforms, both of which have been reported previously
[26]. MIH-a and MIH-b differed from one-another in 9-aa
of their signal peptides and 4-aa of their mature peptides
(Additional file 1: Figure S10). The second isoform was
represented by a C-terminal partial protein (MIH-c;
Additional file 1: Figure S10). The cysteines, which
form disulfide bridges, are conserved between MIH-a
and MIH-b, and the C-terminal fragment of MIH-c
(Additional file 1: Figure S10).
Transcript cluster expression analysis revealed CHH-2
to be differentially expressed across the moult cycle with
elevated levels of transcript abundance in moult stages
A-B and D4 stages (Fig. 5, Table 1). This expression
pattern was strikingly different from other CHH
super-family neuropeptides which were constitutively
expressed across the moult cycle (Fig. 5). Within C.
maenas, studies on the function of CHH have con-
cerned CHH-1 only, the two variants of which arise
by alternative splicing [19, 20, 77–79]. The defining
role of CHH is the mobilization of glycogen resulting
Fig. 5 Gene expression profiles of putative CHH-superfamily neuropeptides within C. maenas central nervous system across the moult cycle and
determine by RNAseq (A-CHH-2; B-CHH-1a; C-CHH-1b; D-CHH-MIH-like; E-MIHa,b; F-MIHc). Only CHH-2 was differentially expressed across the
moult cycle within C. maenas CNS (statistics values given inset; see also Table 1). Data are presented as mean counts per million (CPM + SEM)
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in hyperglycemia and increased titres of CHH are ob-
served when crustaceans are exposed to physiologic-
ally stressful conditions [19]. An elevation in
hemolymph CHH titre is also associated with ecdysis:
paraneurons in the fore- and hind-gut discharge
CHH, which is known to regulate water and ion up-
take during ecdysis [79]. CHH also has an inhibitory
activity on ecdysteroid synthesis of the YO, though in
C. maenas CHH is ~ 10–20 times less potent than
MIH [19, 23]. Numerous CHHs have been identified
across many decapods species; for example, six were
isolated from sinus gland extracts of the kuruma
prawn, Marsupenaeus japonicas, five of which showed
hyperglycemic activity [80]. Similarly, via a recent
transcriptome mining effort, two CHHs were reported
for C. maenas (also identified here: CHH-1 and
CHH-2) and the brachyuran crabs Scylla paramamo-
sain and Eriocheir sinensis, whilst 3 were found in
Macrobrachium rosenbergii and Homarus americanus,
and 7 in Litopenaeus vannamei [27]. The physio-
logical functions for numerous CHHs have been stud-
ied in a variety of decapods and each appear to
perform similar roles, although the potency may vary with
isoform (for detailed review, see [19]).
In contrast to CHH-2, gene expression patterns of
CHH-1a, CHH-1b, CHH-MIH-like, MIH-a,b, MIH-c
were similar to each other (Fig. 5). This could reflect
different roles for CHH-2 relative to CHH-1 and
coupled with differential expression across the moult
cycle, with elevated expression during A-B and D4, may
suggest a role for CHH-2 in ecdysis regulation. Endpoint
PCR revealed that within the CNS, CHH-2 is expressed
in the CG and VG, but not the ESG (Additional file 1:
Figure S7). Given that the primary site of CHH-1 expres-
sion is the X-organ of the ESG, this crude endpoint tissue
distribution has identified likely differences in the neural
architecture of CHH-1 and CHH-2 synthesising perikarya.
Given the differing expression dynamics identified here
between CHH-2 and other CHH-superfamily peptides
(CHH-1/CHH-MIH-like/MIH), coupled with likely differ-
ences in peptide synthesis location, studies of physiological
functions of newly identified CHHs (CHH-like neuropep-
tides) may find diverse roles that differ from those estab-
lished for CHH.
Crustacean female sex hormone (CFSH) and Neuroparsin-3
The recently discovered CFSH is implicated in the devel-
opment of female reproductive characteristics [81]. We
identified transcripts coding for CFSH and two CFSH-
like neuropeptides in the Carma_CNS-transcriptome
(Additional file 1: Figure S11; see also Additional files 2
and 3), the first time the deduced sequences of the
CFSH-like neuropeptides have been reported for this
species [27]. The deduced C. maenas CFSH prepro-
hormone is a 225-aa peptide with a 24-aa signal peptide.
It is cleaved at a KR dibasic cleavage site to produce a
32-aa CFSH-PRP and a 166-aa mature CFSH, which has
8 cysteine residues predicted to form 4 disulfide bridges
(C46-C150, C80-C112, C105-C119, C107-C148) consistent
with that reported for Callinectes sapidus CFSH [81].
CFSH-like 1 prepro-hormone is a 297-aa protein with a
22-aa signal peptide, a 102-aa CFSH-like 1 PRP and a
170-aa mature CFSH-like 1 peptide which has 10 cyst-
eine redisues predicted to form 5 disulfide bridges
(C4-C53, C12-C84, C107-C109, C114-C123, C152-C154). This
deduced prepro-hormone also has a 12-aa N-terminal
extension immediately upstream the start of its signal
peptide (see Additional files 2 and 3). The CFSH-like 2
prepro-hormone codes for a 219-aa protein with a 26-aa
signal peptide and a 193-aa mature peptide with 8 cyst-
eine residues predicted to form 4 disulfide bridges
(C73-C130, C105-C128, C135-C176, C143-C174). CFSH-like 2
prepro-hormone does not contain a PRP. CFSH was
differentially expressed across the moult cycle (F = 6.40,
P = 0.001, FDR = 0.034, Table 1); however, expression
levels were significantly different between males and fe-
males, being expressed at only low levels in males -con-
sistent with previous findings [81]. Two-way ANOVA
showed that the effects of moult stage (F(4,19) = 2.958, P
= 0.047) and sex (F(1,19) = 10.055, P = 0.005) on gene ex-
pression were significant, the interaction between these
factors could not be investigated due to the unbalanced
nature of the data. Hence, we must treat our observation
that CFSH expression varies across the moult cycle with
due caution.
Neuroparsins were first identified as anti-gonadotropic
factors which delay vitellogenesis in insects [82–84].
RNA interference experiments confirmed an inhibitory
effect of neuroparsin on vitellogenesis and oocyte matur-
ation in female desert locusts, Schistocerca gregaria [85].
In contrast, neuroparsin-like ovary ecdysteroidogenic
hormones (OEHs) are gonadotropic and ecdysteroido-
genic in the mosquito Aedes aegypti and ovary maturing
parsins (OMPs) of Locusta migratoria and Schistocerca
gregaria similarly stimulate oocyte growth, probably by
ovarian ecdysone synthesis stimulation [86–88]. In the
shrimp Metapenaeus ensis, RNAi pointed to a role for
neuroparsin in the maturation of oocytes by stimulat-
ing vitellogenin production in the hepatopancreas,
similar to the roles of OEH and OMP [89]. Neuropar-
sins have also been used as markers of phase change
in gregarious locusts, being differentially expressed
between phases. In C. maenas neuroparsin-3 was dif-
ferentially expressed across the moult cycle, elevated
expression was evident in D1 (F = 7.03, P = 0.001,
FDR = 0.024, Table 1), though this finding is subject
to the same caveat as above regarding the unbalanced
numbers of males and females per moult stage.
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Two-way ANOVA was unable to assess interaction
because of the unbalanced nature of the data, but in-
dicated that gene expression was affected by moult
stage (F(4,19) = 3.931, P = 0.017), but not sex (F(1,19) =
0.379, P = 0.545).
Carma_YO-transcriptome
The YO is an endocrine tissue, derived from the epider-
mis and as such expression of neuropeptide transcripts
was not expected. To our surprise however, transcripts
representative of peptides from across 24 families were
identified: 37 transcripts (from 34 clusters) were
found to encode 19 full-length peptides or proteins
(comprising a ‘start’ methionine, a signal peptide, and
a stop codon), 10 C-terminal partial proteins, 5 N-ter-
minal partial proteins and 2 internal (lacking both
termini) fragments (see Additional file 2). Six of these
neuropeptides were expressed at levels > 10 CPM; in-
cluding neuroparsin-1, CHH-1, inotocin/vasopressin,
EH-2, neuroparsin-3, and neuroparsin-4. Notably,
neuroparsin-1 mRNA was differentially expressed
within the YO across the moult cycle (Fig. 6). Thus,
the YO appears to be a source of synthesis (and per-
haps release site) for a number of neuroparsins which,
as mentioned previously, are known to play roles in
reproductive physiology. Neuroparsin-1 expression
was low during inter-moult and early pre-moult (C3–
4, D1) but increased through late pre-moult, peaking
in D4 and remaining elevated during post-moult
(A-B, Fig. 6), therefore marking this YO derived tran-
script as having a putative role in the ecdysis cassette.
Within the Carma_CNS-transcriptome, EH-2 was
rarely expressed and end-point PCR using RNA from
inter-moult (C4) crabs confirmed low expression across
tissues (Additional file 1: Figure S7). However, RNAseq
within the YO revealed high expression of EH-2 in
pre-moult (D3, D4), though this was not found to be
differentially expressed across the moult cycle, presum-
ably due to high variability between biological replicates
(Fig. 6). These findings suggest that the two EHs within
Fig. 6 Gene expression dynamics across the moult cycle of six representative neuropeptides within the YO determined by RNAseq (A-Neuroparsin;
B-CHH-1; C-Inotocin/vasopressin; D-EH2; E-Neuoparsin 3; F-Neuroparsin 4). Bars show mean counts per million: CPM, mean + SEM. Neuroparsin 1
(A) was found to be differentially expressed across the moult cycle (statistics values given inset). CHH-1 was fragmented and clustered into two
clusters, which are included in a single graph (B)
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crustaceans are likely expressed in discrete tissues, per-
haps with discrete physiological functions.
Putative neuropeptide receptor discovery and expression
Carma_CNS-transcriptome
A total of 66 putative neuropeptide GPCRs were discov-
ered within the C. maenas CNS: 100 transcripts (from
72 clusters) were identified, encoding 77 full-length
proteins, 13 C-terminal partial proteins, nine N-terminal
partial proteins, and one likely internal fragment (see
Additional file 2). Of the 77 full-length protein coding
sequences discovered, 63 were predicted to contain 7
transmembrane helixes (predicted by tmhmm). In
addition to these putative GPCRs, one insulin receptor
tyrosine kinase (de-orphanised as a receptor for IAG
[90] and, since it is found in both sexes, likely also a re-
ceptor for other insulin-like ligands [91]) three insulin
receptor-like tyrosine kinases, and two venus kinase re-
ceptors (recently deorphanised in the mosquito Aedes
aegypti as neuroparsin receptors [92]) were identified
(see Additional file 2). Within the Drosophila genome,
49 neuropeptide GPCRs are present, 35 of which have
been functionally characterised [93]. The highly conserved
nature of arthropod (and particularly insect and crust-
acean) neuropeptidomes enabled us to predict putative C.
maenas neuropeptide receptors based on sequence simi-
larity to those de-orphanised in insects [27, 64]. On this
basis, the 66 putative C. maenas neuropeptide GPCRs
have been assigned putative ligands from 33 neuropeptide
families; six C. maenas GPCRs are homologous to orphan
insect GPCRs and thus, at present, cannot be assigned a
ligand: neuropeptide B3 R, CG33639-like, MOODY,
MOODY-like, neuropeptide A47 R, and neuropeptide
A47 R-like. Of the 66 putative neuropeptide receptors, 50
were class A (rhodopsin-like), seven were class B (secre-
tin-like), and nine were leucine-rich repeat-containing
GPCRs (LGR) (Figs. 7, 8, 9) (see also Additional file 2). Of
the neuropeptides present with characterized GPCRs, only
agatoxin-like peptide and periviscerokinin lacked putative
GPCRs. Owing to the lack of characterized receptors for
CCRFamide, CFSH, HIGSLYamide, Hyrg, and Orcokinin,
no putative receptors for these were identified in the
Fig. 7 Rhodopsin-like (class A) putative neuropeptide G protein-coupled phylogenetic tree constructed for C. maenas (Cm), Drosophila melanogaster
(Dm), Tribolium castaneum (Tc), and Anopheles gambiae (Ag). NCBI accession codes and Drosophila gene codes are detailed in the figure
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present study. Red pigment concentrating hormone is
related to adipokinetic hormone and is the putative
ligand of an AKH receptor; one of which was discov-
ered in the Carma_CNS-transcriptome as well as an
AKH/ACP-like receptor, which has similarities to both
AKH and ACP receptors. The AKH receptor identi-
fied here (AKH/RPCH R Fig. 7) was subsequently
de-orphanised and confirmed as the receptor of the
native RPCH neuropeptide [89].
G protein-coupled receptors for ion transport pep-
tide (ITP), which are part of the CHH superfamily
(type 1 CHHs, see [19]), and ITP-like peptides have
been de-orphanised in the silkworm Bombyx mori
[94] In the present study two ITPR-like GPCRs were
discovered (Fig. 7, Additional file 2). Since these
ligand-receptor pairs are likely to be highly conserved,
and given that ITPR-like GPCRs have been identified
in the decapods [32, 51] and may be broadly
Fig. 8 Secretin family (class B) putative neuropeptide G protein-coupled receptor phylogenetic tree constructed for C. maenas (Cm), Drosophila
melanogaster (Dm), Tribolium castaneum (Tc), Bombyx mori (Bm). NCBI accession codes and Drosophila gene codes are detailed in the figure
Fig. 9 Leucine-rich repeat-containing (LGR) putative neuropeptide G protein-coupled receptor phylogenetic tree constructed for C. maenas (Cm), Drosophila
melanogaster (Dm), Tribolium castaneum (Tc), and Nilaparvata lugens (Nl). NCBI accession codes and Drosophila gene codes are detailed in the figure
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represented across crustaceans, this is a potentially
very important avenue that must be pursued further
in an effort to establish a functional CHH receptor
in C. maenas.
The number of putative neuropeptide GPCRs identi-
fied for C. maenas exceeds that determined from insect
genomes for Drosophila (49), Tribolium castaneum (48),
and Bombyx mori (39) and from insect transcriptomes
for Nilaparvata lugens (57) and Chilio suppressalis (51)
[93, 95–98], but is fewer than that determined from che-
licerate genomes for Stegodyphus mimosarum (120) and
Mesobuthus martensii (93) [64]. The relatively large
number of neuropeptide GPCRs in chelicerates, reflected
also in the number of peptide ligands, results from gene
paralogs that have been maintained in most extant cheli-
cerates after ancient genome duplication events [64].
Phylogenetic analysis of putative neuropeptide GPCRs
supports the notion that there are paralogous receptor
genes for a number of neuropeptide receptors within C.
maenas (Figs. 7, 8, 9, Table 2). Four putative CCHa re-
ceptors were discovered which cluster with the Drosoph-
ila CCHa-1 and -2 receptors (CG30106 and CG14593,
respectively: Fig. 7). Two neuropeptide F receptors
(NPFR) and two NFPR-like receptors cluster with the
Drosophila NPFR, CG1147. Finally, three putative ecdy-
sis triggering hormone receptors (ETHR) were discov-
ered and that cluster with Drosophila ETHR (CG5911)
and T. castaneum ETHR (Fig. 7). These are examples of
multiple neuropeptide gene paralogs identified in C.
maenas, but there are numerous others where two
paralogous receptor sequences have been found in the
Carma_CNS-transcriptome but which occur as a single
receptor gene in Drosophila; for instance, the natalisin
receptor, SIFa receptor, sulfakinin receptor, trissin recep-
tor, and proctolin receptor (Fig. 7). A summary of the
deduced number of neuropeptides and putative neuro-
peptide receptor genes is detailed in Table 2. The high
confidence clustering of putative neuropeptide receptors
identified here for C. maenas with those de-orphanised in
Drosophila (and T. castaneum etc.) is strongly suggestive
of the functional identity of the putative ligands (as we
have done). However, the sequence similarities between
GPCRs means that such an approach has potential to be
erroneous and so functional de-orphanisation strategies
are essential in the identification of GPCR transcripts with
their ligands [93].
Only one of the putative neuropeptide receptors
discovered was differentially expressed at the transcript
level across the moult cycle: proctolin R1 (Fig. 10). Two
potential proctolin receptors were discovered (as is
the case for other decapods crustaceans, see Table 2
[29, 51]); gene expression analysis showed that R2
was constitutively expressed across the moult cycle
whilst R1 was more highly expressed during pre- and
post-moult, in stages D4 and A-B, relative to early
inter-moult and early pre-moult, D1 (Fig. 10). A single
neuropeptide proctolin is present in the Carma_CN-
S-transcriptome whilst there are two putative receptors
(Table 2). The presence of two paralogs, coupled with the
differential expression of one across the moult cycle,
suggests that the receptors may have specialized roles and
that proctolin R1 may be important during the moult
cycle. Proctolin is a powerful stimulant of muscle contrac-
tions. For instance in Drosophila, proctolin induced sus-
tained muscle contractions in third instar larvae with the
CNS removed whilst diminished proctolin receptor ex-
pression leads to reduced crawling velocity at high tem-
peratures [99]. In crustaceans, proctolin has been isolated
from the pericardial organs and can affect muscle contrac-
tions of heart and skeletal muscles and modulate pyl-
oric rhythms [100–102]. These reports align with the
necessity for stereotyped muscle contractions evident
during ecdysis as the animal extricates the old cuticle,
and in light of the putative proctolin receptor expres-
sion dynamics it is tempting to speculate that this
peptide and receptor pair plays a role in this regard.
It will be intriguing to investigate tissue specific ex-
pression of the two putative proctolin receptors.
Annotation of the Carma_CNS-transcriptome
resulted in 221 clusters with the GO:0004930 ‘G
protein-coupled receptor activity’. Of these 221 clusters,
eight were found to be differentially expressed across the
moult cycle (one of which was proctolin R1: annotated
as ‘FMRFamide receptor-like’, Cluster-569.17428; Add-
itional file 1: Table S6 and Figure S12). All except for
Cluster-569.40579 (annotated as Fizzled-2-like) were ele-
vated during post- and pre-moult relative to inter-moult
(Additional file 1: Figure S12). With the exception of
proctolin R1 (Cluster-569-17,428), no other GPCRs
showed high sequence similarity to known neuropeptide
receptors. Given that the moult cycle and the process of
ecdysis pervade all levels of crustacean physiology, it is
perhaps unsurprising that non-neuropeptide GPCRs are
differentially expressed across the moult cycle.
Carma_YO-transcriptome
Thirty putative neuropeptide GPCRs were discovered
within the Carma_YO-transcriptome: 43 transcripts
(from 35 clusters) were identified encoding 24 full-
length proteins, seven C-terminal partial proteins, five
N-terminal partial proteins, and seven internal frag-
ments (see Additional file 2). Of these, 25 were predicted
to contain seven transmembrane helices (predicted by
tmhmm). In addition to GPCRs, two venus kinase recep-
tors were identified. Of the 30 putative neuropeptide
GPCRs, 20 were rhodopsin-like, four were secretin-like,
and six were LGR type and were assigned putative
ligands from 24 neuropeptide families based on
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Table 2 Neuropeptide ligand (L) and putative G protein-coupled receptor (R) genes identified within the Carma_CNS-transcriptome
compared with data for selected arthropods
C. maenas H. americanus [29] P. clarkii [51] S. maritima [50] Drosophila [93]
L R L R L R L R L R
ACP 1 2a 1 1 1 1 1 1
AKH\RPCH 1 1a nf 2 1 1 1 1 1 1
Agatoxin-like peptide (ALP) 1 nf
Allatostatin-A 1 1 1 1 1 1 1 1 1 2
Allatostatin-B\MIP 1 2 1 1 1 1 1 1
Allatostatin-C\CC\CCC 1\2\1 1 2 3 2\1\nf 3 1\1\nf nf 1 2
Allatotropin 1 1
Bursicon-a\b 1\1 2 1\1 2 1\1 2 1\1 1 1\1 1
Calcitonin 1 1 1 nf
CAPA 1 1
CCHamide 2 4 2 2 2 2 2 1 2 2
CCRFamide 1 ? 1 n?
CNMamide 1 1 1 1
Corazonin 1 1 1 1 1 1 1 2 1 1
CRF-like DH (DH44) 1 1 1 2 1 1 1 1 1 2
CCAP 1 1 1 1 1 nf 1 1 1 1
CFSH 1 ? 1 ?
CFSH-like 2 ? 2 ?
CHH 2 ? 4 ? 2 ?
CHH-MIH-like 1 ? 2 ?
DH31 1 1 1 3 1 1 1 1 1 1
EH 2 2 2 nf 2 2 2 2
Carcikinin\ETH 1 3 nf 3 nf 2 1 2 1 1
EFLamide 1 1 1 nf 1 nf
Elevenin-like peptide 1 2 1 nf 1 nf
FMRFamide 1 1 1 1 1 1 2 1 1 1
GPA2\GPB5 1\1 2 1\1 1 1\1 1
HIGSLYRamide 5 ?
Hyrg 1 ?
ILP 1 1 1 2 1 1 1 nf
Intocin 1 2 1 nf 1 2 1 2
ITP nf 2 1 nf
Leucokinin 1 1 2 1 1 1 1 1
MIH 1 ? 1 ?
Myosuppressin 1 2 1 1 1 2 1 2 1 2
Natalisin 1 2 1 1 1 1
Neuroparsin 4 2 1 nf 3 2
NPF 2 2a 1 4 2 3 1 1 1 1
Orcokinin 2 ? 1 ? 1 ?
Periviscerokinin 1 nf 1 1
PDH\ePDH 3\1 3 1 2 3 4 1 1
Proctolin 1 2 1 2 1 2 1 1 1 1
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sequence similarity to de-orphanised neuropeptide
GPCRs (see Additional file 2). Transcripts for the puta-
tive neuropeptide receptors allatostatin-A R, CRZR,
CCAPR, short neuropeptide F receptor (sNPFR), and
bursicon R2, encoded full-length proteins in the YO,
whilst those identified from the Carma_CNS-transcrip-
tome were incomplete. In addition, whilst a single
calcitonin-like-DH-31 R was identified from the Car-
ma_CNS-transcriptome, an additional three transcript
variants were identified in the Carma_YO-transcriptome
(see Additional file 2). Of the putative neuropeptide re-
ceptors identified in the YO, seven were differentially
expressed across the moult cycle (Table 3, Fig. 11).
sNPFR was the most differentially expressed cluster over
the moult cycle within the Carma_YO-transcriptome,
with low expression levels throughout most of the moult
cycle, but was upregulated during early pre-moult, D1
(Table 3, Fig. 11A).
Annotation of the Carma_YO-transcriptome annotated
160 clusters with ‘GO:0004930 G protein-coupled receptor
activity’. Of these, 18 were found to be differentially
expressed across the moult cycle (Additional file 1: Table
S9 and Figure S13), one of which was sNPFR and another
was allatostatin-B/myoinhibitory peptide R1. Of the
remaining 16 GPCRs, which did not have high sequence
similarity to known neuropeptide receptors, 12 contained 7
transmembrane helixes (predicted by tmhmm). Differential
expression of GPCRs within the YO, the location of ecdys-
teroid synthesis, is suggestive of a role for these GPCRs in
ecydsis control.
Carma_YO_vs_Epi-transcriptome
Given that the YO is pivotal in moult control via its
central role in ecdysteroid synthesis, we anticipated that
elucidation of GPCRs and their expression dynamics
within this tissue might yield insight to receptor-ligand
pairs critical to moult regulation. Our strategy was to
explore differential expression between the YO and epi-
dermis, from which it is derived, to separate transcripts
exclusive to the YO. Differential expression of clusters
between YO and epidermis tissues during inter-moult
(C3–4) identified 162 clusters annotated as GPCRs
Table 2 Neuropeptide ligand (L) and putative G protein-coupled receptor (R) genes identified within the Carma_CNS-transcriptome
compared with data for selected arthropods (Continued)
C. maenas H. americanus [29] P. clarkii [51] S. maritima [50] Drosophila [93]
L R L R L R L R L R
Pyrokinin 1 1 2 1 1 1 1 2 2 3
Relaxin-like 2 3 1 nf
RYamide 1 1 1 1 1 1 1 1
short Neuropeptide F 1 1 nf 1 1 1 1 1
SIFamide 1 2 1 1 1 2 1 2 1 1
Sulfakinin 2 2 1 1 1 2 1 3 1 1
TRP 1 1 1 3 1 2 1 1 1 2
Trissin 1 2 1 nf 1 2
Data from H. americanus [29], P. clarkii [51], S. maratima [50], and Drosophila [93]. For C. maenas, a = additional receptors with sequence similarity identified: 1×
ACP/AKH R, 2× NPF-like R. nf = not found,? = receptor not known. See also Table 1 of Veenstra 2016 for a similar comparison of neuropeptide ligand and receptor
genes for numerous arthropod species including arachnids [64]
Fig. 10 Putative proctolin receptor 1 (panel A) and 2 (panel B) gene expression across the moult cycle within C. maenas central nervous system,
determined by RNAseq (data expressed as counts per million, CPM + SEM)
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(‘GO: GO:0004930 G protein-coupled receptor activity’),
11 of which were upregulated in the YO relative to the
epidermis (Table 4, Fig. 12) and of these, eight were pre-
dicted to contain 7 transmembrane helices (predicted by
TMHMM). Three of the GPCRs upregulated in the YO
relative to the epidermis were essentially absent from
the epidermis, and two were also differentially expressed
in the YO across the moult cycle; rhodopsin G0-coupled
and probable G protein-coupled receptor Methuselah
(Mth)-like 1 (Table 4, Fig. 12). The GPCR cluster that
showed most marked differential expression between YO
and epidermis tissues was annotated as a gonadotropin-
releasing hormone receptor and, according to our phylo-
genetic analysis of rhodopsin-like GPCRs (Fig. 7), was a
candidate for the corazonin receptor (CRZR) (Table 4,
Fig. 13). Corazonin initiates the release of ETH from ‘Inka’
cells in M. sexta, so the identification of a putative CRZR
on the YO was exciting. Analysis of the Carma_YO-tran-
scriptome revealed that this receptor was not differentially
expressed over the moult cycle (Table 4, Fig. 13B). Differ-
ential expression of CRZR between YO and epidermis was
validated by qPCR: two-way ANOVA revealed no
interaction effect (tissue x moult stage), but main ef-
fects revealed a significant difference in CRZR mRNA
expression between tissues (being greater in the YO;
F(1,46) = 63.3, P < 0.001) but not across moult stage, F(4, 46)
= 1.01, P = 0.412 (Fig. 13C, D).
We also performed qPCR on CNS tissues to verify
expression patterns of both the peptide CRZ and the
putative CRZR (Fig. 14). In silico data for CRZ revealed
no differential expression across the moult cycle. Two
way ANOVA of qPCR data however, showed that whilst
there was no interaction between moult cycle and differ-
ent CNS tissues, main effects were significant for tissue
(F(2,71) = 482.77, P < 0.001) and moult stage (F(4,71) = 4.27,
P = 0.004). Pairwise comparisons with Bonferroni correc-
tion post hoc analysis indicated that moult stage D1
differed from all other stages (P < 0.05), mRNA abun-
dances being higher during this stage. For tissues, CRZ
mRNA abundance was significantly greater within the
ESG relative to CG and VG (P < 0.05). For the putative
CRZR within the CNS, in silico data showed no dif-
ferential gene expression across the moult cycle.
Two-way ANOVA of CRZR qPCR data revealed no
interaction between moult stage and tissue, but main
effects were significant for tissue (F(2,71) = 4.75, P =
0.0116); Bonferroni post-hoc analysis showed that VG
CRZR mRNA expression was greater than ESG and
CG (P < 0.05; Fig. 14D). Expression values for CRZR
determined via qPCR show that expression levels
within all regions of the CNS were low relative to ex-
pression within the YO (Figs. 13D, 14D). This puta-
tive CRZR has subsequently been de-orphanised as
the receptor to the native CRZ neuropeptide [31].
CRZ qPCR identified the primary location of peptide
synthesis within the CNS to be the eyestalk ganglion
(ESG, Fig. 14), whilst CRZR was expressed at far higher
values in the YO relative to all parts of the CNS. Intri-
guingly, given the crucial role of the YO to ecdysteroido-
genesis and therefore ecdysis, high values for CRZR
expression in the YO clearly indicate a hitherto un-
known and unexpected role for this ligand-receptor pair
in ecdysis regulation.
Conclusions
The Carma_CNS-, Carma_YO-, and Carma_YO_v-
s_Epi- transcriptomes presented here provide a high
quality resource for transcript discovery in relation to
crustacean ecdysis regulation. The Carma_CNS-tran-
scriptome represents the most complete crustacean tran-
scriptome published to date in terms of neuropeptide
and neuropeptide receptor sequence diversity and com-
pleteness. Moreover, the temporal element of this study
has enabled the first comprehensive exploration of puta-
tive crustacean neuropeptide signaling across the moult
cycle and across multiple tissues. Within the CNS of C.
maenas, the neuropeptides carcikinin/ETH, CHH-2, and
CCAP were differentially expressed across the moult
cycle and are, therefore, anticipated to play important
roles in the regulation of ecdysis. ETH and CCAP are
Table 3 Putative neuropeptide G protein-coupled receptor differential expression statistics
Putative neuropeptide
GPCR
Cluster LogFC F P FDR
A-B D1 D3 D4
Short neuropeptide F R Cluster-4928.1 −0.48 5.09 −0.90 −0.56 50.25 2.45E-11 1.24E-06
Bursicon R2 Cluster-136,339.5130 2.78 0.90 3.04 3.70 9.81 7.49E-05 0.002
CCHa R1 Cluster-136,339.27034 4.93 11.30 7.01 3.68 10.80 7.82E-05 0.002
Relaxin R3 Cluster-136,999.0 4.38 5.89 2.70 0.85 9.70 8.10E-05 0.002
ITPR-like Cluster-133,078.1 1.18 −0.40 1.20 1.55 5.84 0.002 0.016
MOODY-like Cluster-136,339.8771 1.22 1.84 2.37 2.00 5.07 0.004 0.025
Ast-B/MIP-R1 Cluster-136,339.8223 1.34 0.34 1.10 1.79 4.59 0.011 0.049
Differential gene expression analysis statistics (F, P, FDR) for seven C. maenas putative neuropeptide G protein-coupled receptors which were differentially
expressed across the moult cycle within the Y organ. LogFC are relative to C3–4. The P-value should be read in conjunction with the false discovery rate (FDR)
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fundamental to the temporal regulation of ecdysis in in-
sects and release of CCAP during crustacean ecdysis is
concomitant with the onset of ecdysis motor programme.
The probable roles for both carcikinin/ETH and CCAP in
crustacean ecdysis hint at conserved commonalities be-
tween insect and crustacean ecdysis cassettes. CHH-2,
previously not studied, is now a neuropeptide of interest
with respect to ecdysis physiology. The differing gene ex-
pression dynamics of CHH-2 relative to CHH-1, MIHs,
and CHH-MIH-like peptides found here suggests that these
CHHs may fulfil different physiological functions. However,
since the translation and processing of functional peptides
may be temporally uncoupled from mRNA expression,
conclusions peptides availability and bioactivity of these
cannot be inferred from mRNA abundance without due
caution. A putative proctolin R1 was differentially expressed
across the moult cycle, which marks a novel association of
proctolin with ecdysis, but no other putative neuropeptide
GPCR was found to be differentially expressed across the
moult cycle in the CNS of C. maenas.
To our surprise, neuropeptide transcripts were discov-
ered within the YO and amongst these neuroparsin-1
was found to be differentially expressed across the moult
cycle, highlighting the YO as a source of neuropeptide
Fig. 11 Gene expression patterns across the moult cycle within the YO for differentially expressed putative neuropeptide receptors (see Table 3
for statistics), determined by RNAseq (A-sNPFR; B-Bursicon R2; C-CCHa R1; D-Relaxin R3; E-ITPR-like; F-MOODY-like; G-Ast-B/MIP-R1). Data
are expressed as mean counts per million, CPM + SEM)
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Fig. 13 Corazonin receptor (CRZR) gene expression within epidermis and Y-organs (A, C) and across the moult cycle within the Y-organ (B, D) of
C. maenas, determined by RNAseq A, B and qPCR C, D. For qPCR data, CRZR mRNA copy numbers are normalized to the geometric mean of the
reference genes elongation factor 1-alpha and ubiquitin-conjugating enzyme E2 L3 (bars show mean values +SEM). In silico data are presented
as counts per million (CPM + SEM)
Fig. 12 Gene expression profiles of representative clusters annotated ‘GO:0004930 GPCR activity’ and upregulated in YO relative to epidermis of
C. maenas during inter-moult (C3–4), and across the moult cycle within the YO (Carma_YO-transcriptome). See Table 4 for clusters differentially
expressed in YO across the moult cycle. Data are expressed as counts per million (CPM + SEM)
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synthesis. A number of putative neuropeptide receptors
were identified as being differentially expressed across
the moult cycle within the YO and, given that the only
known function of the YO is synthesis of ecdysteroids,
are putative candidates in ecdysis regulation.
Our analysis revealed relatively few GPCRs specific to
the YO (compared to the epidermis). The most differ-
entially expressed of these were essentially absent
from epidermis and included a receptor annotated as
gonadotropin-releasing hormone receptor which, con-
sidering phylogenetic grouping was revealed as a can-
didate corazonin receptor. Tantalisingly, this putative
CRZR was strongly expressed in the YO relative to the
epidermis, and was lowly expressed in the CNS, suggest-
ing an unexpected and potentially very important role for
CRZ-CRZR pair in ecdysis regulation.
The comprehensive list of putative GPCRs discov-
ered here provides a basis from which receptor
de-orphanisation may advance, which is absolutely ne-
cessary to enable neuropeptide and receptor pair
function to be defined.
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